Dr. Trisha Wise-Draper, MD,PhD
Claim this profileUniversity of Cincinnati Medical Center
Studies Squamous Cell Carcinoma
Studies Solid Tumors
22 reported clinical trials
54 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
Stage III
p16 positive
2Solid Tumors
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Trisha Wise-Draper, MD,PhD is currently running
Voyager V1 + Cemiplimab
for Melanoma
This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will enroll patients with three distinct separate tumor cohorts. The cancers types are colorectal, head and neck carcinoma, and melanoma that are progressing on CPI treatment.
Recruiting1 award Phase 2
Radiation Therapy + Cisplatin
for Head and Neck Cancer
This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting1 award Phase 219 criteria
More about Trisha Wise-Draper, MD,PhD
Clinical Trial Related4 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 13 Active Clinical TrialsTreatments Trisha Wise-Draper, MD,PhD has experience with
- Pembrolizumab
- Cisplatin
- Nivolumab
- Radiation Therapy
- RP1
- Carboplatin
Breakdown of trials Trisha Wise-Draper, MD,PhD has run
Squamous Cell Carcinoma
Solid Tumors
Thyroid Cancer
Head and Neck Cancers
Head and Neck Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Trisha Wise-Draper, MD,PhD specialize in?
Trisha Wise-Draper, MD,PhD focuses on Squamous Cell Carcinoma and Solid Tumors. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are Stage III.
Is Trisha Wise-Draper, MD,PhD currently recruiting for clinical trials?
Yes, Trisha Wise-Draper, MD,PhD is currently recruiting for 13 clinical trials in Cincinnati Ohio. If you're interested in participating, you should apply.
Are there any treatments that Trisha Wise-Draper, MD,PhD has studied deeply?
Yes, Trisha Wise-Draper, MD,PhD has studied treatments such as Pembrolizumab, Cisplatin, Nivolumab.
What is the best way to schedule an appointment with Trisha Wise-Draper, MD,PhD?
Apply for one of the trials that Trisha Wise-Draper, MD,PhD is conducting.
What is the office address of Trisha Wise-Draper, MD,PhD?
The office of Trisha Wise-Draper, MD,PhD is located at: University of Cincinnati Medical Center, Cincinnati, Ohio 45219 United States. This is the address for their practice at the University of Cincinnati Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.